Microbiota‐dependent metabolite trimethylamine‐N‐oxide is associated with disease severity and survival of patients with chronic heart failure

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2796|277|6|717-726

ISSN： 0954-6820

Source： JOURNAL OF INTERNAL MEDICINE, Vol.277, Iss.6, 2015-06, pp. : 717-726

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Distance between Patients’ Subjective Perceptions and Objectively Evaluated Disease Severity in Chronic Heart Failure

By  

Psychotherapy and Psychosomatics, Vol. 72, Iss. 3, 2003-04 ,pp. : 166-170

Karger

Access to resources Recommend Favorite

The impact of disease severity on EQ-5D and SF-6D utility discrepancies in chronic heart failure

By Kontodimopoulos Nick   Argiriou Michalis   Theakos Nikolaos   Niakas Dimitris  

The European Journal of Health Economics, Vol. 12, Iss. 4, 2011-08 ,pp. : 383-391

Springer Publishing Company

Access to resources Recommend Favorite

Prevalence and Prognostic Impact of Chronic Obstructive Pulmonary Disease in Patients with Chronic Heart Failure: Data from the GISSI-HF Trial

By  

Cardiology, Vol. 136, Iss. 2, 2016-09 ,pp. : 128-137

Karger

Access to resources Recommend Favorite

Telemedical Care and Monitoring for Patients with Chronic Heart Failure Has a Positive Effect on Survival

By  

HEALTH SERVICES RESEARCH, Vol. 53, Iss. 1, 2018-02 ,pp. : 532-555

John Wiley & Sons Inc

Access to resources Recommend Favorite

Disrupted Serotonergic and Sympathoadrenal Systems in Patients with Chronic Heart Failure May Serve as New Therapeutic Targets and Novel Biomarkers to Assess Severity, Progression and Response to Treatment

By  

Cardiology, Vol. 113, Iss. 4, 2009-03 ,pp. : 277-286

Karger

Access to resources Recommend Favorite